# Abbott Laboratories (ABT) — Q4-2012 Earnings Results

**Report date:** 2013-01-23 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABT/earnings/Q4-2012

## Post-Earnings Brief

### Headline

Abbott Labs Beats on EPS, Stock Down 0.27%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.51 | N/A | +0.80% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism regarding future growth. They emphasized the importance of innovation and market adaptation.

**Key quotes:**

> Management highlighted strong performance in key product segments.

> They acknowledged challenges in the market but expressed confidence in long-term growth.

### Guidance Changes

No forward guidance was provided during this earnings call.

### What It Means

Abbott Labs reported an earnings per share that beat expectations, but the stock still fell slightly by 0.27%. This decline may reflect investor concerns about the lack of revenue data and forward guidance. The cautious tone from management suggests they are aware of market challenges, which could impact future performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABT/earnings/Q4-2012_